The crucial role of allergists in the clinical management and treatment of eosinophilic esophagitis.

IF 2.6 Q2 ALLERGY
D Gargano, L Franceschini, R Polillo, C M Rossi, D Bignardi, D Villalta, F Buzzulini, G Cortellini, E Pinter, M B Bilò, A Farsi
{"title":"The crucial role of allergists in the clinical management and treatment of eosinophilic esophagitis.","authors":"D Gargano, L Franceschini, R Polillo, C M Rossi, D Bignardi, D Villalta, F Buzzulini, G Cortellini, E Pinter, M B Bilò, A Farsi","doi":"10.23822/EurAnnACI.1764-1489.402","DOIUrl":null,"url":null,"abstract":"<p><strong>Summary: </strong>Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus affecting mainly young individuals with a high burden of comorbid atopic diseases and is associated with increased morbidity. Proton pump inhibitors (PPIs) is often the first line of treatment by inducing clinical remission in 30-50% of patients. Recently new drugs, such as budesonide orodispersible tablets and a monoclonal antibody targeting interleukin-4 and 13, have been found to be effective in clinical trials and approved to treat this condition. A prompt diagnosis and correct management of these patients is of paramount importance to prevent fibrostenosis of the oesophagus and to improve the quality of life. The complex management of patients living with EoE requires the integrated cooperation of several specialists, including allergists, gastroenterologists, pathologists, dietitians, and psychologist.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European annals of allergy and clinical immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23822/EurAnnACI.1764-1489.402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Summary: Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus affecting mainly young individuals with a high burden of comorbid atopic diseases and is associated with increased morbidity. Proton pump inhibitors (PPIs) is often the first line of treatment by inducing clinical remission in 30-50% of patients. Recently new drugs, such as budesonide orodispersible tablets and a monoclonal antibody targeting interleukin-4 and 13, have been found to be effective in clinical trials and approved to treat this condition. A prompt diagnosis and correct management of these patients is of paramount importance to prevent fibrostenosis of the oesophagus and to improve the quality of life. The complex management of patients living with EoE requires the integrated cooperation of several specialists, including allergists, gastroenterologists, pathologists, dietitians, and psychologist.

变态反应科医师在嗜酸性粒细胞性食管炎的临床管理和治疗中的关键作用。
摘要:嗜酸性粒细胞性食管炎(EoE)是一种慢性食管炎症性疾病,主要影响伴有高负担特应性疾病的年轻人,并与发病率增加相关。质子泵抑制剂(PPIs)通常是通过诱导30-50%的患者临床缓解的第一线治疗。最近一些新药,如布地奈德分散片和针对白细胞介素-4和13的单克隆抗体,在临床试验中被发现是有效的,并被批准用于治疗这种疾病。及时诊断和正确治疗这些患者对于预防食道纤维狭窄和提高生活质量至关重要。EoE患者的复杂管理需要几位专家的综合合作,包括过敏症专家、胃肠病学家、病理学家、营养师和心理学家。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
0.00%
发文量
102
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信